Xing Guo

4.2k total citations · 2 hit papers
47 papers, 3.7k citations indexed

About

Xing Guo is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Xing Guo has authored 47 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Biomedical Engineering, 27 papers in Biomaterials and 16 papers in Molecular Biology. Recurrent topics in Xing Guo's work include Nanoparticle-Based Drug Delivery (27 papers), Nanoplatforms for cancer theranostics (23 papers) and RNA Interference and Gene Delivery (9 papers). Xing Guo is often cited by papers focused on Nanoparticle-Based Drug Delivery (27 papers), Nanoplatforms for cancer theranostics (23 papers) and RNA Interference and Gene Delivery (9 papers). Xing Guo collaborates with scholars based in China, United States and New Zealand. Xing Guo's co-authors include Shaobing Zhou, Yi Wang, Jingya Zhao, Jie Wang, Wei Xiao, Chunli Shi, Jingmei Pan, Guang Yang, Zhaomin Tang and Xiang Xiong and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Xing Guo

46 papers receiving 3.6k citations

Hit Papers

Polarization of Tumor-Ass... 2021 2026 2022 2024 2021 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Guo China 32 2.3k 1.8k 1.1k 582 556 47 3.7k
Shuangjiang Yu China 33 1.7k 0.8× 1.2k 0.6× 809 0.7× 704 1.2× 525 0.9× 77 3.5k
Xiangrui Liu China 32 2.0k 0.9× 1.6k 0.9× 2.4k 2.1× 684 1.2× 522 0.9× 121 4.9k
Ju Hee Ryu South Korea 35 2.5k 1.1× 1.7k 0.9× 2.3k 2.0× 1.1k 2.0× 387 0.7× 72 5.2k
Ying Piao China 26 1.7k 0.8× 1.4k 0.8× 1.3k 1.1× 504 0.9× 328 0.6× 61 3.1k
Shun Shen China 38 2.7k 1.2× 1.8k 1.0× 1.3k 1.2× 1.3k 2.2× 307 0.6× 76 4.3k
Jinrong Peng China 39 3.0k 1.3× 1.9k 1.0× 1.1k 0.9× 982 1.7× 563 1.0× 93 4.6k
Chenggen Qian China 32 2.1k 0.9× 1.0k 0.6× 1.1k 1.0× 1.1k 1.9× 332 0.6× 54 3.6k
Weijing Yang China 37 2.5k 1.1× 1.3k 0.7× 1.4k 1.2× 995 1.7× 792 1.4× 69 4.1k
Shixian Lv China 36 1.8k 0.8× 2.2k 1.2× 1.5k 1.3× 645 1.1× 328 0.6× 80 4.1k
Chen Jiang China 41 1.9k 0.8× 2.3k 1.3× 3.2k 2.9× 579 1.0× 450 0.8× 78 5.8k

Countries citing papers authored by Xing Guo

Since Specialization
Citations

This map shows the geographic impact of Xing Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Guo more than expected).

Fields of papers citing papers by Xing Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Guo. The network helps show where Xing Guo may publish in the future.

Co-authorship network of co-authors of Xing Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Guo. A scholar is included among the top collaborators of Xing Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Guo. Xing Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ming, Yushu Dong, Lixiang Li, et al.. (2025). Photoactivatable immunostimulatory nanoengineered microalgae for boosting cascade-activated antitumor immunity. Science Advances. 11(41). eadw4212–eadw4212.
2.
Jin, Li, et al.. (2025). Biomimetic Nanoparticles Inhibit the HIF-1α/iNOS/NLRP3 Pathway to Alleviate Rheumatoid Arthritis. Nano Letters. 25(10). 3807–3816. 7 indexed citations
3.
Wang, Zhenhua, et al.. (2024). M2 Macrophage‐Derived Exosomes Inhibiting Neutrophil Extracellular Traps for Ischemic Stroke Therapy. Advanced Functional Materials. 34(42). 13 indexed citations
4.
Yuan, Ruiting, Yan Li, Zhenhua Wang, et al.. (2023). Enhanced chemodynamic therapy and immunotherapy by hypoxia augmentation for tumor ablation. Nano Today. 51. 101899–101899. 22 indexed citations
5.
Li, Ran, et al.. (2023). Relieving thrombo-inflammation with acid-triggered polymersomes toward ischemic stroke therapy. Nano Today. 54. 102114–102114. 10 indexed citations
6.
Guo, Xing, Hanping Li, Yongjian Liu, et al.. (2022). Endogenous Retrovirus Elements Are Co-Expressed with IFN Stimulation Genes in the JAK–STAT Pathway. Viruses. 15(1). 60–60. 10 indexed citations
7.
Xiong, Xiang, et al.. (2021). Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy. Nano Today. 39. 101225–101225. 76 indexed citations
8.
Pan, Jingmei, Xilin Li, Funeng Xu, et al.. (2021). Self‐Blockade of PD‐L1 with Bacteria‐Derived Outer‐Membrane Vesicle for Enhanced Cancer Immunotherapy. Advanced Materials. 34(7). e2106307–e2106307. 107 indexed citations
9.
Guo, Xing, Baihao Shao, Shaobing Zhou, Ivan Aprahamian, & Zi Chen. (2020). Visualizing intracellular particles and precise control of drug release using an emissive hydrazone photochrome. Chemical Science. 11(11). 3016–3021. 31 indexed citations
10.
Yan, Haimeng, Mengmeng Dong, Xinling Liu, et al.. (2019). Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression. Cancer Letters. 446. 38–48. 41 indexed citations
11.
Sun, Huili, Xing Guo, Yi Wang, et al.. (2019). A multifunctional liposomal nanoplatform co-delivering hydrophobic and hydrophilic doxorubicin for complete eradication of xenografted tumors. Nanoscale. 11(38). 17759–17772. 31 indexed citations
12.
Jing, Yuting, Xiang Yuan Xiong, Yang Ming, et al.. (2018). A Multifunctional Micellar Nanoplatform with pH‐Triggered Cell Penetration and Nuclear Targeting for Effective Cancer Therapy and Inhibition to Lung Metastasis. Advanced Healthcare Materials. 7(7). e1700974–e1700974. 40 indexed citations
13.
Tang, Zhaomin, Dan Li, Huili Sun, et al.. (2014). Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density. Biomaterials. 35(27). 8015–8027. 67 indexed citations
14.
Wang, Jie, Guang Yang, Xing Guo, et al.. (2014). Redox-responsive polyanhydride micelles for cancer therapy. Biomaterials. 35(9). 3080–3090. 125 indexed citations
15.
Shi, Chunli, Xing Guo, Qianqian Qu, et al.. (2014). Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles. Biomaterials. 35(30). 8711–8722. 163 indexed citations
16.
Guo, Xing, et al.. (2013). pH-triggered intracellular release from actively targeting polymer micelles. Biomaterials. 34(18). 4544–4554. 200 indexed citations
17.
Zhou, Shaobing, Jing Fan, Sujit S. Datta, et al.. (2013). Thermally Switched Release from Nanoparticle Colloidosomes. Advanced Functional Materials. 23(47). 5925–5929. 49 indexed citations
18.
Chen, Tao, Xing Guo, Xian Liu, et al.. (2012). A Strategy in The Design of Micellar Shape for Cancer Therapy. Advanced Healthcare Materials. 1(2). 214–224. 43 indexed citations
19.
Zhou, Qi, et al.. (2011). Preparation and characterization of thermosensitive pluronic F127-b-poly(ɛ-caprolactone) mixed micelles. Colloids and Surfaces B Biointerfaces. 86(1). 45–57. 75 indexed citations
20.
Huang, Chi, Yangbo Zhou, Zhaomin Tang, et al.. (2011). Synthesis of multifunctional Fe3O4 core/hydroxyapatite shell nanocomposites by biomineralization. Dalton Transactions. 40(18). 5026–5026. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026